{"transactions":[{"id":4617384,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":45614,"kind":"person","name":"GROVES REGINA E","position":1,"cik":"0001653877","reported_name":"GROVES REGINA E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-14T21:44:50.000Z","date":"2026-09-11","kind":"sale","planned":false,"acquired":false,"shares":5313,"price":54.22,"value":288070.86,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $54.09 to $54.38 per share. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":34546,"source":{"system":"sec-edgar","filing":"0001653877-26-000006","document":"wk-form4_1789422288.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1653877/000165387726000006/wk-form4_1789422288.xml","form_type":"4"}},{"id":769704,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":45614,"kind":"person","name":"GROVES REGINA E","position":1,"cik":"0001653877","reported_name":"GROVES REGINA E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-20T13:25:28.000Z","date":"2026-05-18","kind":"grant","planned":false,"acquired":true,"shares":6144,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date."}],"balance_after":39859,"source":{"system":"sec-edgar","filing":"0001653877-26-000004","document":"wk-form4_1779283525.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1323885/000165387726000004/wk-form4_1779283525.xml","form_type":"4"}},{"id":775050,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":45614,"kind":"person","name":"GROVES REGINA E","position":1,"cik":"0001653877","reported_name":"GROVES REGINA E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-18T22:30:22.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":11117,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units. The shares subject to the restricted stock units vest over a period of four years, with 1/4th of such shares vesting 12 months after May 14, 2026, and 1/16th of such shares vesting at the end of every three month period thereafter over the remaining 36 months, subject to continued service for Issuer on each vesting date."}],"balance_after":28099,"source":{"system":"sec-edgar","filing":"0001653877-26-000001","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000165387726000001/ownership.xml","form_type":"4"}},{"id":1071230,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":45614,"kind":"person","name":"GROVES REGINA E","position":1,"cik":"0001653877","reported_name":"GROVES REGINA E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-08T13:12:12.000Z","date":"2025-08-06","kind":"sale","planned":false,"acquired":false,"shares":2452,"price":36.82,"value":90282.64,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $36.75 to $36.84 per share. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":33715,"source":{"system":"sec-edgar","filing":"0001653877-25-000004","document":"wk-form4_1754658730.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1323885/000165387725000004/wk-form4_1754658730.xml","form_type":"4"}},{"id":1138801,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":45614,"kind":"person","name":"GROVES REGINA E","position":1,"cik":"0001653877","reported_name":"GROVES REGINA E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-21T20:41:39.000Z","date":"2025-05-19","kind":"grant","planned":false,"acquired":true,"shares":5401,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date."}],"balance_after":36167,"source":{"system":"sec-edgar","filing":"0001323885-25-000058","document":"wk-form4_1747860092.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1323885/000132388525000058/wk-form4_1747860092.xml","form_type":"4"}},{"id":1142733,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":45614,"kind":"person","name":"GROVES REGINA E","position":1,"cik":"0001653877","reported_name":"GROVES REGINA E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-19T21:32:32.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":8982,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units. The shares subject to the restricted stock units vest over a period of four years, with 1/4th of such shares vesting 12 months after May 15, 2025, and 1/16th of such shares vesting at the end of every three month period thereafter over the remaining 36 months, subject to continued service for Issuer on each vesting date."}],"balance_after":16982,"source":{"system":"sec-edgar","filing":"0000950170-25-074601","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000095017025074601/ownership.xml","form_type":"4"}},{"id":1508997,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":45614,"kind":"person","name":"GROVES REGINA E","position":1,"cik":"0001653877","reported_name":"GROVES REGINA E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-20T22:05:57.000Z","date":"2024-05-16","kind":"grant","planned":false,"acquired":true,"shares":5481,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vest over a period of four years, with 1/4th of such shares vesting 12 months after May 16, 2024, and 1/16th of such shares vesting at the end of every three month period thereafter over the remaining 36 months, subject to the reporting person's continued service for Issuer on each vesting date."}],"balance_after":5481,"derivative":{"exercise_price":22.5,"expiration_date":"2034-05-15","underlying":"Common Stock","underlying_shares":5481},"source":{"system":"sec-edgar","filing":"0000950170-24-062570","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000095017024062570/ownership.xml","form_type":"4"}},{"id":1508996,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":45614,"kind":"person","name":"GROVES REGINA E","position":1,"cik":"0001653877","reported_name":"GROVES REGINA E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-20T22:05:57.000Z","date":"2024-05-16","kind":"grant","planned":false,"acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units. The shares subject to the restricted stock units vest over a period of four years, with 1/4th of such shares vesting 12 months after May 16, 2024, and 1/16th of such shares vesting at the end of every three month period thereafter over the remaining 36 months, subject to continued service for Issuer on each vesting date."}],"balance_after":8000,"source":{"system":"sec-edgar","filing":"0000950170-24-062570","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000095017024062570/ownership.xml","form_type":"4"}},{"id":1517147,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":45614,"kind":"person","name":"GROVES REGINA E","position":1,"cik":"0001653877","reported_name":"GROVES REGINA E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-14T21:05:26.000Z","date":"2024-05-13","kind":"grant","planned":false,"acquired":true,"shares":7788,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date."}],"balance_after":30766,"source":{"system":"sec-edgar","filing":"0001323885-24-000081","document":"wk-form4_1715720715.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1323885/000132388524000081/wk-form4_1715720715.xml","form_type":"4"}},{"id":1876101,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":45614,"kind":"person","name":"GROVES REGINA E","position":1,"cik":"0001653877","reported_name":"GROVES REGINA E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-26T20:11:54.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":3186,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date."}],"balance_after":22978,"source":{"system":"sec-edgar","filing":"0001323885-23-000057","document":"wk-form4_1685131876.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1323885/000132388523000057/wk-form4_1685131876.xml","form_type":"4"}},{"id":1882675,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":45614,"kind":"person","name":"GROVES REGINA E","position":1,"cik":"0001653877","reported_name":"GROVES REGINA E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-22T20:55:33.000Z","date":"2023-05-18","kind":"grant","planned":false,"acquired":true,"shares":6759,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest over a period of four years, with 1/4th of such shares vesting 12 months after May 18, 2023, and 1/16th of such shares vesting at the end of every three month period thereafter over the remaining 36 months, subject to the reporting person's continued service for Issuer on each vesting date."}],"balance_after":6759,"derivative":{"exercise_price":35.58,"expiration_date":"2033-05-17","underlying":"Common Stock","underlying_shares":6759},"source":{"system":"sec-edgar","filing":"0001209191-23-031496","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919123031496/doc4.xml","form_type":"4"}},{"id":2067766,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":45614,"kind":"person","name":"GROVES REGINA E","position":1,"cik":"0001653877","reported_name":"GROVES REGINA E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-04T21:39:38.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vest over a period of four years, with 1/4th of such shares vesting 12 months after January 3, 2023, and 1/16th of such shares vesting at the end of every three month period thereafter over the remaining 36 months, subject to the reporting person's continued service for Issuer on each vesting date."}],"balance_after":10000,"derivative":{"exercise_price":30.66,"expiration_date":"2033-01-02","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-23-000986","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919123000986/doc4.xml","form_type":"4"}},{"id":2067765,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":45614,"kind":"person","name":"GROVES REGINA E","position":1,"cik":"0001653877","reported_name":"GROVES REGINA E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-04T21:39:38.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units. The shares subject to the restricted stock units vest over a period of four years, with 1/4th of such shares vesting 12 months after January 3, 2023, and 1/16th of such shares vesting at the end of every three month period thereafter over the remaining 36 months, subject to the reporting person's continued service for Issuer on each vesting date."}],"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001209191-23-000986","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919123000986/doc4.xml","form_type":"4"}},{"id":2252944,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":45614,"kind":"person","name":"GROVES REGINA E","position":1,"cik":"0001653877","reported_name":"GROVES REGINA E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-27T13:03:50.000Z","date":"2022-05-25","kind":"grant","acquired":true,"shares":3564,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date."}],"balance_after":19792,"source":{"system":"sec-edgar","filing":"0001323885-22-000075","document":"wf-form4_165365661622442.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1323885/000132388522000075/wf-form4_165365661622442.xml","form_type":"4"}},{"id":2531658,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":45614,"kind":"person","name":"GROVES REGINA E","position":1,"cik":"0001653877","reported_name":"GROVES REGINA E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-29T20:30:45.000Z","date":"2021-04-30","kind":"purchase","acquired":true,"shares":34,"price":76.68,"value":2607.12,"ownership":{"direct":true},"balance_after":16228,"source":{"system":"sec-edgar","filing":"0001209191-21-062074","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1323885/000120919121062074/doc4.xml","form_type":"4"}},{"id":2565322,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":45614,"kind":"person","name":"GROVES REGINA E","position":1,"cik":"0001653877","reported_name":"GROVES REGINA E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-17T20:45:39.000Z","date":"2021-09-15","kind":"sale","acquired":false,"shares":3156,"price":74.73,"value":235847.88,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $73.17 to $75.37 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":16194,"source":{"system":"sec-edgar","filing":"0001209191-21-056653","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1323885/000120919121056653/doc4.xml","form_type":"4"}},{"id":2690933,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":45614,"kind":"person","name":"GROVES REGINA E","position":1,"cik":"0001653877","reported_name":"GROVES REGINA E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-28T20:05:37.000Z","date":"2021-05-26","kind":"sale","acquired":false,"shares":4208,"price":71.95,"value":302765.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $71.81 to $72.07 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":19350,"source":{"system":"sec-edgar","filing":"0001209191-21-036518","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1323885/000120919121036518/doc4.xml","form_type":"4"}},{"id":2698440,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":45614,"kind":"person","name":"GROVES REGINA E","position":1,"cik":"0001653877","reported_name":"GROVES REGINA E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-24T20:43:13.000Z","date":"2021-05-20","kind":"grant","acquired":true,"shares":1749,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date."}],"balance_after":23558,"source":{"system":"sec-edgar","filing":"0001209191-21-035348","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1323885/000120919121035348/doc4.xml","form_type":"4"}},{"id":3029820,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":45614,"kind":"person","name":"GROVES REGINA E","position":1,"cik":"0001653877","reported_name":"GROVES REGINA E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-16T20:12:38.000Z","date":"2020-09-14","kind":"sale","acquired":false,"shares":6313,"price":41.83,"value":264072.79,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $41.61 to $42.26 per share. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":21809,"source":{"system":"sec-edgar","filing":"0001209191-20-050690","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1323885/000120919120050690/doc4.xml","form_type":"4"}},{"id":3136762,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":45614,"kind":"person","name":"GROVES REGINA E","position":1,"cik":"0001653877","reported_name":"GROVES REGINA E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-22T12:21:38.000Z","date":"2020-05-20","kind":"grant","acquired":true,"shares":2452,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date."}],"balance_after":28122,"source":{"system":"sec-edgar","filing":"0001209191-20-031556","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1323885/000120919120031556/doc4.xml","form_type":"4"}},{"id":3413667,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":45614,"kind":"person","name":"GROVES REGINA E","position":1,"cik":"0001653877","reported_name":"GROVES REGINA E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-09-16T11:28:20.000Z","date":"2019-09-12","kind":"purchase","acquired":true,"shares":500,"price":24.86,"value":12430.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $24.82 to $24.87 per share. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":25670,"source":{"system":"sec-edgar","filing":"0001209191-19-049552","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1323885/000120919119049552/doc4.xml","form_type":"4"}},{"id":3511457,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":45614,"kind":"person","name":"GROVES REGINA E","position":1,"cik":"0001653877","reported_name":"GROVES REGINA E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-24T12:45:52.000Z","date":"2019-05-22","kind":"grant","acquired":true,"shares":4208,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date."}],"balance_after":25170,"source":{"system":"sec-edgar","filing":"0001209191-19-032570","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1323885/000120919119032570/doc4.xml","form_type":"4"}},{"id":3878760,"issuer":{"id":11998,"kind":"organization","name":"REVA Medical, Inc.","symbol":"RVA.AX"},"owners":[{"id":45614,"kind":"person","name":"GROVES REGINA E","position":1,"cik":"0001653877","reported_name":"GROVES REGINA E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-07-02T19:40:19.000Z","date":"2018-06-29","kind":"purchase","acquired":true,"shares":9815.7,"price":1.53,"value":15018.021,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the purchase of 98,157 of the Issuer's CHESS Depositary Interests (CDIs) trading on the Australian Securities Exchange."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The purchase was executed in the form of CDIs, trading on the Australian Securities Exchange, and as such the purchase price has been converted to a USD equivalent, adjusting for the conversion ratio of 1 share of common stock per 10 CDIs, and the exchange rate on the date of the transaction."}],"balance_after":245924.2,"source":{"system":"sec-edgar","filing":"0001209191-18-040511","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496268/000120919118040511/doc4.xml","form_type":"4"}},{"id":3910414,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":45614,"kind":"person","name":"GROVES REGINA E","position":1,"cik":"0001653877","reported_name":"GROVES REGINA E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-01T20:23:38.000Z","date":"2018-05-31","kind":"grant","acquired":true,"shares":5272,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date."}],"balance_after":20962,"source":{"system":"sec-edgar","filing":"0001209191-18-034682","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1323885/000120919118034682/doc4.xml","form_type":"4"}},{"id":3918298,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":45614,"kind":"person","name":"GROVES REGINA E","position":1,"cik":"0001653877","reported_name":"GROVES REGINA E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-24T20:34:49.000Z","date":"2018-05-22","kind":"grant","acquired":true,"shares":5221,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date."}],"balance_after":15690,"source":{"system":"sec-edgar","filing":"0001209191-18-032989","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1323885/000120919118032989/doc4.xml","form_type":"4"}},{"id":3925817,"issuer":{"id":11998,"kind":"organization","name":"REVA Medical, Inc.","symbol":"RVA.AX"},"owners":[{"id":45614,"kind":"person","name":"GROVES REGINA E","position":1,"cik":"0001653877","reported_name":"GROVES REGINA E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-05-18T21:00:17.000Z","date":"2018-05-16","kind":"grant","acquired":true,"shares":226000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable as follows: 25% of the shares vest on May 16, 2019 with the remaining shares vesting at the rate of 2.0833% per month thereafter until fully vested."}],"balance_after":226000,"derivative":{"exercise_price":1.96,"expiration_date":"2028-05-16","underlying":"Common Stock","underlying_shares":226000},"source":{"system":"sec-edgar","filing":"0001209191-18-031614","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1496268/000120919118031614/doc4.xml","form_type":"4"}},{"id":3925816,"issuer":{"id":11998,"kind":"organization","name":"REVA Medical, Inc.","symbol":"RVA.AX"},"owners":[{"id":45614,"kind":"person","name":"GROVES REGINA E","position":1,"cik":"0001653877","reported_name":"GROVES REGINA E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock (RSUs)","published_at":"2018-05-18T21:00:17.000Z","date":"2018-05-16","kind":"grant","acquired":true,"shares":114000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units (RSUs) convert into shares of Common Stock on a one-for-one basis.  The RSUs vest in three (3) equal annual installments beginning on May 16, 2019."}],"balance_after":236108.5,"source":{"system":"sec-edgar","filing":"0001209191-18-031614","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496268/000120919118031614/doc4.xml","form_type":"4"}},{"id":4023399,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":45614,"kind":"person","name":"GROVES REGINA E","position":1,"cik":"0001653877","reported_name":"GROVES REGINA E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-01T21:03:02.000Z","date":"2018-03-01","kind":"purchase","acquired":true,"shares":1000,"price":17.43,"value":17430.0,"ownership":{"direct":true},"balance_after":10469,"source":{"system":"sec-edgar","filing":"0001209191-18-014940","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1323885/000120919118014940/doc4.xml","form_type":"4"}},{"id":4221535,"issuer":{"id":11998,"kind":"organization","name":"REVA Medical, Inc.","symbol":"RVA.AX"},"owners":[{"id":45614,"kind":"person","name":"GROVES REGINA E","position":1,"cik":"0001653877","reported_name":"GROVES REGINA E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-08-30T20:25:18.000Z","date":"2017-08-29","kind":"purchase","acquired":true,"shares":386.5,"price":6.368,"value":2461.232,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the purchase of 3,865 of the Issuer's CHESS Depository Interests (CDIs) trading on the Australian Securities Exchange."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The purchase was executed in the form of CDIs, trading on the Australian Securities Exchange, and as such the purchase price has been converted to a USD equivalent, adjusting for the conversion ratio of 1 share of common stock per 10 CDIs, and the exchange rate on the date of the transaction."}],"balance_after":122108.5,"source":{"system":"sec-edgar","filing":"0001209191-17-050830","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1496268/000120919117050830/doc4.xml","form_type":"4"}},{"id":4221534,"issuer":{"id":11998,"kind":"organization","name":"REVA Medical, Inc.","symbol":"RVA.AX"},"owners":[{"id":45614,"kind":"person","name":"GROVES REGINA E","position":1,"cik":"0001653877","reported_name":"GROVES REGINA E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-08-30T20:25:18.000Z","date":"2017-08-23","kind":"purchase","acquired":true,"shares":407.7,"price":6.371,"value":2597.4567,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the purchase of 4,077 of the Issuer's CHESS Depository Interests (CDIs) trading on the Australian Securities Exchange."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The purchase was executed in the form of CDIs, trading on the Australian Securities Exchange, and as such the purchase price has been converted to a USD equivalent, adjusting for the conversion ratio of 1 share of common stock per 10 CDIs, and the exchange rate on the date of the transaction."}],"balance_after":121722,"source":{"system":"sec-edgar","filing":"0001209191-17-050830","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496268/000120919117050830/doc4.xml","form_type":"4"}},{"id":4228572,"issuer":{"id":11998,"kind":"organization","name":"REVA Medical, Inc.","symbol":"RVA.AX"},"owners":[{"id":45614,"kind":"person","name":"GROVES REGINA E","position":1,"cik":"0001653877","reported_name":"GROVES REGINA E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-08-21T18:25:23.000Z","date":"2017-08-21","kind":"purchase","acquired":true,"shares":402.4,"price":5.864,"value":2359.6736,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the purchase of 4,024 of the Issuer's Chess Depository Interests (CDIs) trading on the Australian Securities Exchange."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The purchase was executed in the form of CDIs, trading on the Australian Securities Exchange, and as such the purchase price has been converted to a USD equivalent, adjusting for the conversion ratio of 1 share of common stock per 10 CDIs, and the exchange rate on the date of the transaction."}],"balance_after":121314.3,"source":{"system":"sec-edgar","filing":"0001209191-17-049754","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1496268/000120919117049754/doc4.xml","form_type":"4"}},{"id":4228571,"issuer":{"id":11998,"kind":"organization","name":"REVA Medical, Inc.","symbol":"RVA.AX"},"owners":[{"id":45614,"kind":"person","name":"GROVES REGINA E","position":1,"cik":"0001653877","reported_name":"GROVES REGINA E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-08-21T18:25:23.000Z","date":"2017-08-17","kind":"purchase","acquired":true,"shares":303.4,"price":5.57,"value":1689.938,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the purchase of 3,034 of the Issuer's Chess Depository Interests (CDIs) trading on the Australian Securities Exchange."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The purchase was executed in the form of CDIs, trading on the Australian Securities Exchange, and as such the purchase price has been converted to a USD equivalent, adjusting for the conversion ratio of 1 share of common stock per 10 CDIs, and the exchange rate on the date of the transaction."}],"balance_after":120911.9,"source":{"system":"sec-edgar","filing":"0001209191-17-049754","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496268/000120919117049754/doc4.xml","form_type":"4"}},{"id":4310038,"issuer":{"id":11998,"kind":"organization","name":"REVA Medical, Inc.","symbol":"RVA.AX"},"owners":[{"id":45614,"kind":"person","name":"GROVES REGINA E","position":1,"cik":"0001653877","reported_name":"GROVES REGINA E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2017-05-22T20:16:44.000Z","date":"2017-05-19","kind":"grant","acquired":true,"shares":58500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares vest on May 19, 2018, with the remaining shares vesting at 2.08333% per month thereafter until fully vested."}],"balance_after":58500,"derivative":{"exercise_price":6.71,"expiration_date":"2027-05-19","underlying":"Common Stock","underlying_shares":58500},"source":{"system":"sec-edgar","filing":"0001209191-17-034532","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1496268/000120919117034532/doc4.xml","form_type":"4"}},{"id":4310037,"issuer":{"id":11998,"kind":"organization","name":"REVA Medical, Inc.","symbol":"RVA.AX"},"owners":[{"id":45614,"kind":"person","name":"GROVES REGINA E","position":1,"cik":"0001653877","reported_name":"GROVES REGINA E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-05-22T20:16:44.000Z","date":"2017-05-19","kind":"grant","acquired":true,"shares":29250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis. These restricted stock units shall vest annually on the anniversary date of the grant (May 19), with the first vesting occurring on May 19, 2018, at the rate of 33.3% annually, until fully vested."}],"balance_after":120608.5,"source":{"system":"sec-edgar","filing":"0001209191-17-034532","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496268/000120919117034532/doc4.xml","form_type":"4"}},{"id":4373402,"issuer":{"id":2704,"kind":"organization","name":"AtriCure, Inc.","symbol":"ATRC"},"owners":[{"id":45614,"kind":"person","name":"GROVES REGINA E","position":1,"cik":"0001653877","reported_name":"GROVES REGINA E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-03-23T20:10:05.000Z","date":"2017-03-21","kind":"grant","acquired":true,"shares":9469,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest 33% annually over three years from date of grant."}],"balance_after":9469,"source":{"system":"sec-edgar","filing":"0001209191-17-022558","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1323885/000120919117022558/doc4.xml","form_type":"4"}},{"id":4374907,"issuer":{"id":11998,"kind":"organization","name":"REVA Medical, Inc.","symbol":"RVA.AX"},"owners":[{"id":45614,"kind":"person","name":"GROVES REGINA E","position":1,"cik":"0001653877","reported_name":"GROVES REGINA E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2017-03-22T17:49:25.000Z","date":"2017-03-20","kind":"grant","acquired":true,"shares":175500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares vest on March 20, 2018, with the remaining shares vesting at 2.08333% per month thereafter until fully vested."}],"balance_after":175500,"derivative":{"exercise_price":7.72,"expiration_date":"2027-03-20","underlying":"Common Stock","underlying_shares":175500},"source":{"system":"sec-edgar","filing":"0001209191-17-022397","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1496268/000120919117022397/doc4.xml","form_type":"4"}},{"id":4374906,"issuer":{"id":11998,"kind":"organization","name":"REVA Medical, Inc.","symbol":"RVA.AX"},"owners":[{"id":45614,"kind":"person","name":"GROVES REGINA E","position":1,"cik":"0001653877","reported_name":"GROVES REGINA E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-03-22T17:49:25.000Z","date":"2017-03-20","kind":"grant","acquired":true,"shares":87750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis.  These restricted stock units shall vest annually on the anniversary date of the grant (March 20), with the first vesting occurring on March 20, 2018, at the rate of 33.3% annually, until fully vested."}],"balance_after":91358.5,"source":{"system":"sec-edgar","filing":"0001209191-17-022397","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496268/000120919117022397/doc4.xml","form_type":"4"}}]}